Tuesday November 24 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Vascular Therapeutics Incorporated

Cardiovascular diseases - the molecular basis for excessive blood clotting.


Contact Details:
700 E. El Camino Real Suite 270
Mountain View
CA
94040
United States of America
Tel:415 903 5979
Fax:415 903 9065
Email:

Loading...

Recent Publications by Vascular Therapeutics Incorporated:

Cardiopulmonary complications of sickle cell disease: role of nitric oxide and hemolytic anemia.
Medical advances in the management of patients with sickle cell disease,...
5th November, 2009
Vascular Therapeutics Section, Cardiovascular, Branch, National Heart Lung Hematology Am Soc Hematol Educ Program. 2005:51-7.
DOI Direct Link
Phasic hemodynamics and reverse blood flows in the aortic isthmus and pulmonary arteries of preterm lambs with pulmonary vascular dysfunction.
Time-domain representations of the fetal aortopulmonary circulation were...
31st January, 2009
Physiopathology and Vascular Therapeutics, School of Medicine, University Am J Physiol Heart Circ Physiol. 2008 Dec;295(6):H2231-41. Epub 2008 Sep
DOI Direct Link
Potential role of statin therapy in heart failure, atrial fibrillation and aortic stenosis.
3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors, or statins,...
1st November, 2006
Emory University School of Medicine, Division of Cardiology, In Vascular Future Cardiol. 2006 Nov;2(6):687-93.
DOI Direct Link
Levels of soluble endothelium-derived adhesion molecules in patients with sickle cell disease are associated with pulmonary hypertension, organ dysfunction, and mortality.
Endothelial cell adhesion molecules orchestrate the recruitment and...
28th October, 2005
Vascular Therapeutics Section, Cardiovascular Branch, National Heart, Lung Br J Haematol. 2005 Sep;130(6):943-53.
DOI Direct Link
Enzymatic function of hemoglobin as a nitrite reductase that produces NO under allosteric control.
Hypoxic vasodilation is a fundamental, highly conserved physiological...
12th October, 2005
Vascular Therapeutics Section, Cardiovascular Branch, National Heart, Lung J Clin Invest. 2005 Aug;115(8):2099-107. Epub 2005 Jul 21.
DOI Direct Link

View more Vascular Therapeutics Incorporated research publications.

BioNews Results for Vascular Therapeutics Incorporated:

OXiGENE to Present at American Society of Hematology and AACR/NCI/EORTC Meetings
Pharmacy Choice:  Nov 13 2009 6:25AM Matching: vascular therapeutics
Key RNAi-Based Drugs in the Clinic
GenomeWeb:  Nov 11 2009 8:32PM Matching: vascular therapeutics
DJO Incorporated Announces Financial Results for Third Quarter 2009
SmartBrief:  Oct 28 2009 9:58PM Matching: vascular therapeutics
Third quarter 2009 financial results announced by DJO
News-Medical.Net:  Oct 28 2009 12:20PM Matching: vascular therapeutics
Medical News: Yale Researchers Awarded Grant To Develop Treatment Of Williams Syndrome
Medical News Today:  Oct 27 2009 10:05PM Matching: vascular therapeutics
Promote your company here: BioNewsCast - Press Release Distribution

View more Vascular Therapeutics Incorporated news.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 276 times since April 2007, the link to the organisation's website has been followed 0 times

Search for more companies in Mountain View

Search for more companies in CA



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Vascular Therapeutics Incorporated

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.